Dr. Sebastian Himbert is the Co-Founder and Chief Technology Officer of Synth-Med Biotechnology, a Toronto-based company developing targeted drug delivery technologies that use red blood cells as carriers.
His research at McMaster University focused on the molecular structure and dynamics of blood, including how biological membranes can be manipulated at the nanoscale and integrated into smart biomedical technologies. His journey demonstrates how deep scientific discovery can evolve into a commercial venture when strong research, practical applications, and market needs align.